10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 16, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Cash flows from operating activities: | |||
| Net income | $ 6,939 | 5,158 | 5,081 |
| Depreciation and amortization | 2,108 | 2,092 | 1,286 |
| Stock-based compensation expense | 322 | 408 | 403 |
| Deferred income taxes | (607) | (108) | (189) |
| Other items, net | (399) | (116) | 103 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (420) | 136 | (38) |
| Inventories | 481 | 327 | (7) |
| Other assets | 155 | (1) | (59) |
| Accounts payable | (12) | 228 | 60 |
| Accrued income taxes | 509 | (103) | (326) |
| Other liabilities | 1 | 534 | (23) |
| Net cash provided by operating activities | 9,077 | 8,555 | 6,291 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (594) | (718) | (693) |
| Cash paid for acquisitions, net of cash acquired | (359) | (165) | (9,434) |
| Purchases of intangible assets | (55) | (285) | 0 |
| Purchases of marketable securities | (25,977) | (25,878) | (21,965) |
| Proceeds from sales of marketable securities | 18,029 | 16,697 | 19,123 |
| Proceeds from maturities of marketable securities | 3,527 | 4,199 | 5,090 |
| Proceeds from sale of property, plant and equipment | 274 | 3 | 20 |
| Change in restricted investments, net | 0 | 533 | (520) |
| Other | (392) | (138) | (90) |
| Net cash used in investing activities | (5,547) | (5,752) | (8,469) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 3,465 | 4,476 | 8,054 |
| Repayment of debt | (2,400) | (5,605) | (3,371) |
| Repurchases of common stock | (1,867) | (138) | (832) |
| Dividends paid | (2,396) | (1,851) | (1,415) |
| Net proceeds from issuance of common stock in connection with the Companys equity award programs | 82 | 186 | 296 |
| Settlement of contingent consideration obligations | (253) | (92) | 0 |
| Other | 252 | 147 | (6) |
| Net cash (used in) provided by financing activities | (3,117) | (2,877) | 2,726 |
| Increase (decrease) in cash and cash equivalents | 413 | (74) | 548 |
| Cash and cash equivalents at beginning of period | 3,731 | 3,805 | |
| Cash and cash equivalents at end of period | 4,144 | 3,731 | 3,805 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |